EUROPE STEM CELL MARKET FORECAST 2017-2025
KEY FINDINGS
The Europe Stem cell market is estimated at $ 2010 million in the year 2016 and expected to reach $ 4540 million in the year 2025 at a CAGR of 9.38% during the forecast period 2017-2025.The base year considered for the study is 2016 and the forecast period is between 2017 and 2025. The government’s subsidy and sustenance in the field of stem cell market, increasing investments in R&D and surge in neurodegenerative ailments are some of the factors driving the stem cell market. Also, improvements in the implementation of stem cell, good growth in medical tourism and an enlarged stem cell banking are the dominant drivers in the stem cell market.
MARKET INSIGHTS
Stem cell market is segmented by products, by technology, by production market, and by the application. The stem cell market by products is segmented on the basis of Adult Stem cell market and human embryonic stem cell market. The adult stem cell market is further divided into Hematopoietic stem cell market, Mesenchymal stem cell market, neural stem cell market, dental stem cell market and umbilical cord stem cell market. Human embryonic stem cell market is further divided into induced pluripotent stem cell market and RAT Neural Stem Cell market. The Stem cell market by technology is segmented on the basis of Stem cell acquisition market, stem cell production market, Stem cell Cryopreservation market, stem cell expansion and subculture market. The stem cell market by application is further divided into stem cell regenerative medicine market and drug discovery and development market.
COMPETITIVE INSIGHTS
Major players for the Stem Cell market are Celgene corporation Fibrocell science, Cellartis AB (acquired by Takara holdings Inc.), GE Healthcare, Thermo fisher scientific Pvt Ltd, Stem cell technologies, Cellular dynamics international (holding company Fujifilm), Vericel corporation (Aastrom bioscience), Brainstorm cell therapeutics, Cytori therapeutics Inc California stem cell Inc. (Holding company Caladrius biosciences, Inc. ), Beckton Dickinson and company, Biotime Inc., Stryker corporation,. Some major companies involved in stem cell are; GE Healthcare, Stem cell technology, Thermo Fisher, Becton, Corning and many others.
The Europe Stem cell market is estimated at $ 2010 million in the year 2016 and expected to reach $ 4540 million in the year 2025 at a CAGR of 9.38% during the forecast period 2017-2025.The base year considered for the study is 2016 and the forecast period is between 2017 and 2025. The government’s subsidy and sustenance in the field of stem cell market, increasing investments in R&D and surge in neurodegenerative ailments are some of the factors driving the stem cell market. Also, improvements in the implementation of stem cell, good growth in medical tourism and an enlarged stem cell banking are the dominant drivers in the stem cell market.
MARKET INSIGHTS
Stem cell market is segmented by products, by technology, by production market, and by the application. The stem cell market by products is segmented on the basis of Adult Stem cell market and human embryonic stem cell market. The adult stem cell market is further divided into Hematopoietic stem cell market, Mesenchymal stem cell market, neural stem cell market, dental stem cell market and umbilical cord stem cell market. Human embryonic stem cell market is further divided into induced pluripotent stem cell market and RAT Neural Stem Cell market. The Stem cell market by technology is segmented on the basis of Stem cell acquisition market, stem cell production market, Stem cell Cryopreservation market, stem cell expansion and subculture market. The stem cell market by application is further divided into stem cell regenerative medicine market and drug discovery and development market.
COMPETITIVE INSIGHTS
Major players for the Stem Cell market are Celgene corporation Fibrocell science, Cellartis AB (acquired by Takara holdings Inc.), GE Healthcare, Thermo fisher scientific Pvt Ltd, Stem cell technologies, Cellular dynamics international (holding company Fujifilm), Vericel corporation (Aastrom bioscience), Brainstorm cell therapeutics, Cytori therapeutics Inc California stem cell Inc. (Holding company Caladrius biosciences, Inc. ), Beckton Dickinson and company, Biotime Inc., Stryker corporation,. Some major companies involved in stem cell are; GE Healthcare, Stem cell technology, Thermo Fisher, Becton, Corning and many others.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
4. MARKET DETERMINANTS
4.1. MARKET DRIVER
4.1.1. UPSURGE IN NEURODEGENERATIVE AILMENTS
4.1.2. INVESTMENTS IN R&D IS GROWING
4.1.3. GOVERNMENT SUBSIDY AND SUSTENANCE
4.1.4. ADVANCEMENTS IN THE APPLICATIONS OF STEM CELL
4.1.5. SIGNIFICANT GROWTH IN MEDICAL TOURISM
4.1.6. SWELLING STEM CELL BANKING
4.2. MARKET RESTRAINTS
4.2.1. STEM CELL TREATMENT INCURS HUGE COST
4.2.2. AVERSION IN REIMBURSEMENT POLICIES
4.3. MARKET OPPORTUNITIES
4.3.1. RISING INVESTMENT IN THE STEM CELL MARKET
4.3.2. REPLACED THE USE OF ANIMAL TISSUES FOR THE EXPERIMENTS
4.3.3. GROWING INCOME OF THE PEOPLE ALL ACROSS THE WORLD
4.3.4. CONTINUE SUPPORT OF CONTRACT RESEARCH INDUSTRY
4.4. MARKET CHALLENGES
4.4.1. STRINGENT GOVERNMENT REGULATIONS
4.4.2. FEWER RESPONSIVENESS IN THE DEVELOPED ECONOMIES
5. MARKET SEGMENTATION
5.1. BY PRODUCTS
5.1.1. ADULT STEM CELL MARKET
5.1.1.1. HEMATOPOIETIC STEM CELL MARKET
5.1.1.2. MESENCHYMAL STEM CELL MARKET
5.1.1.3. NEURAL STEM CELL MARKET
5.1.1.4. DENTAL STEM CELL MARKET
5.1.1.5. UMBILICAL CORD STEM CELL MARKET
5.1.2. HUMAN EMBRYONIC STEM CELL
5.1.3. INDUCED PLURIPOTENT STEM CELL MARKET
5.1.4. RAT NEURAL STEM CELL MARKET
5.2. BY TECHNOLOGY
5.2.1. STEM CELL ACQUISITION MARKET
5.2.1.1. STEM CELL BONE MARROW MARKET
5.2.1.2. STEM CELL APHERESIS MARKET
5.2.1.3. STEM CELL UMBILICAL CORD BLOOD MARKET
5.2.2. STEM CELL PRODUCTION MARKET
5.2.2.1. THERAPEUTIC CLONING FOR STEM CELL MARKET
5.2.2.2. IVF STEM CELL MARKET
5.2.2.3. STEM CELL CULTURE MARKET
5.2.3. STEM CELL CRYOPRESERVATION MARKET
5.2.4. STEM CELLS EXPANSION AND SUB-CULTURE MARKET
5.3. STEM CELLS MARKET BY APPLICATION
5.3.1. STEM CELLS REGENERATIVE MEDICINE MARKET
5.3.2. DRUG DISCOVERY AND DEVELOPMENT MARKET
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. VALUE CHAIN ANALYSIS
6.4. OPPORTUNITY MATRIX
6.5. KEY BUYING CRITERIA
6.5.1. HIGH PRICE
6.5.2. EFFICACY
6.5.3. APPLICATION AND EFFECTIVENESS
6.5.4. ACCURACY
6.6. STRATEGIC RECOMMENDATION & STRATEGIC CONCLUSIONS
6.7. VENDOR LANDSCAPE
7. GEOGRAPHICAL ANALYSIS
7.1. EUROPE STEM CELL MARKET
7.1.1. UK STEM CELL MARKET
7.1.2. FRANCE STEM CELL MARKET
7.1.3. GERMANY STEM CELL MARKET
7.1.4. SPAIN STEM CELL MARKET
7.1.5. ITALY STEM CELL MARKET
7.1.6. ROE STEM CELL MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.1.1. TOP WINNING STRATEGIES
9. COMPANY PROFILE
9.1. CYTORI THERAPEUTICS INC.
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT ANALYSIS
9.1.4. STRATEGIC ANALYSIS
9.2. FIBROCELL SCIENCE
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. CELLARTIS AB (ACQUIRED BY TAKARA HOLDINGS INC.)
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. STRATEGIC INITIATIVES
9.3.4. SCOT ANALYSIS
9.3.5. STRATEGIC ANALYSIS
9.4. BIOTIME INC.
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. SCOT ANALYSIS
9.4.4. STRATEGIC ANALYSIS
9.5. GE HEALTHCARE
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. THERMO FISHER SCIENTIFIC PVT. LTD
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVE
9.6.4. SCOT ANALYSIS
9.6.5. STRATEGIC ANALYSIS
9.7. STEMCELL TECHNOLOGIES
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT ANALYSIS
9.7.5. STRATEGIC ANALYSIS
9.8. CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT ANALYSIS
9.8.5. STRATEGIC ANALYSIS
9.9. VERICEL CORPORATION (AASTROM BIOSCIENCE)
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. BRAINSTORM CELL THERAPEUTICS
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. SCOT ANALYSIS
9.10.4. STRATEGIC ANALYSIS
9.11. CALIFORNIA STEM CELL INC. (HOLDING COMPANY CALADRIUS BIOSCIENCES, INC)
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGICINITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGICANALYSIS
9.12. BECKTON DICKINSON AND COMPANY
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. SCOT
9.12.4. STRATEGIC ANALYSIS
9.13. STRYKER CORPORATION
9.13.1. OVERVIEW
9.13.2. PRODUCTPORTFOLIO
9.13.3. SCOT
9.13.4. STRATEGICANALYSIS
9.14. CORNING INC.
9.14.1. OVERVIEW
9.14.2. PRODUCT PORTFOLIO
9.14.3. SCOT ANALYSIS
9.14.4. STRATEGIC ANALYSIS
9.15. CELGENE CORPORATION
9.15.1. OVERVIEW
9.15.2. PRODUCTPORTFOLIO
9.15.3. STRATEGIC INITIATIVE
9.15.4. SCOT ANALYSIS
9.15.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 EUROPE STEM CELLS MARKET BY PRODUCTS 2017-2025 ($ MILLION)
TABLE 2 ADULT STEM CELL MARKET 2017-2025 ($ MILLION)
TABLE 3 EUROPE STEM CELL MARKET IN HEMATOPOITIC STEM CELL 2017-2025 ($ MILLION)
TABLE 4 EUROPE STEM CELL MARKET IN MESENCHYMAL STEM CELL 2017-2025 ($ MILLION)
TABLE 5 EUROPE STEM CELL MARKET IN NEURAL STEM CELL 2017-2025 ($ MILLION)
TABLE 6 EUROPE STEM CELL MARKET IN DENTAL STEM CELL 2017-2025 ($ MILLION)
TABLE 7 EUROPE STEM CELL MARKET IN UMBILICAL CORD STEM CELL 2017-2025 ($ MILLION)
TABLE 8 EUROPE STEM CELL MARKET IN HUMAN EMBRYONIC STEM CELL 2017-2025 ($ MILLION)
TABLE 9 EUROPE STEM CELLS MARKET IN INDUCED PLURIPOTENT STEM CELL 2017-2025 ($ MILLION)
TABLE 10 EUROPE STEM CELL MARKET IN RAT NEURAL STEM CELL 2017-2025 ($ MILLION)
TABLE 11 EUROPE STEM CELL MARKET BY TECHNOLOGY 2017-2025 ($ MILLION)
TABLE 12 EUROPE STEM CELL ACQUISITION MARKET 2017-2025 ($ MILLION)
TABLE 13 EUROPE STEM CELL BONE MARROW MARKET 2017-2025 ($ MILLION)
TABLE 14 EUROPE STEM CELL APHERESIS MARKET -2025 ($ MILLION)
TABLE 15 EUROPE STEM CELL UMBLICAL CORD BLOOD MARKET 2017-2025 ($ MILLION)
TABLE 16 EUROPE STEM CELL PRODUCTION MARKET 2017-2025 ($ MILLION)
TABLE 17 EUROPE STEM CELL PRODUCTION MARKET -2025 ($ MILLION)
TABLE 18 EUROPE STEM CELL THERAPEUTIC CLONING MARKET -2025 ($ MILLION)
TABLE 19 EUROPE IVF STEM CELL MARKET -2025 ($ MILLION)
TABLE 20 EUROPE STEM CELL CULTURE MARKET -2025 ($ MILLION)
TABLE 21 EUROPE STEM CELL CRYOPRESERVATION MARKET -2025 ($ MILLION)
TABLE 22 EUROPE STEM CELL EXPANSION AND SUB-CULTURE MARKET -2025 ($ MILLION)
TABLE 23 EUROPE STEM CELLS MARKET BY APPLICATION 2017-2025 ($ MILLION)
TABLE 24 EUROPE STEM CELLS REGENERATIVE MEDICINE MARKET -2025 ($ MILLION)
TABLE 25 EUROPE DRUG DISCOVERY AND DEVELOPMENT MARKET -2025 ($ MILLION)
TABLE 26 EUROPE STEM CELL MARKET 2017-2025($ MILLION)
FIGURES LIST
FIGURE 1 EUROPE STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 2 KEY FINDINGS OF STEM CELL MARKET
FIGURE 3 NIH SPENDING ON STEM CELL RESEARCH BY THE YEAR 2013-2016 IN USD $BILLION
FIGURE 4 NIH SPENDING ON STEM CELL, BY YEARS (USD BILLIONS)
FIGURE 5 EUROPE STEM CELLS MARKET BY PRODUCTS 2017-2025 ($ MILLION)
FIGURE 6 EUROPE STEM CELLS MARKET IN ADULT STEM CELL 2017-2025 ($ MILLION)
FIGURE 7 EUROPE STEM CELL MARKET IN HUMAN EMBRYONIC STEM CELL 2017-2025 ($ MILLION)
FIGURE 8 EUROPE STEM CELLS MARKET IN INDUCED PLURIPOTENT STEM CELL 2017-2025 ($ MILLION)
FIGURE 9 EUROPE STEM CELL MARKET IN RAT NEURAL STEM CELL 2017-2025 ($ MILLION)
FIGURE 10 EUROPE STEM CELL MARKET BY TECHNOLOGY 2017-2025 ($ MILLION)
FIGURE 11 EUROPE STEM CELL MARKET BY ACQUISITION 2017-2025 ($ MILLION)
FIGURE 12 EUROPE STEM CELL BONE MARROW MARKET 2017-2025 ($ MILLION)
FIGURE 13 EUROPE STEM CELL APHERESIS MARKET 2017-2025 ($ MILLION)
FIGURE 14 EUROPE STEM CELL UMBILICAL CORD BLOOD MARKET 2017-2025 ($ MILLION)
FIGURE 15 EUROPE STEM CELL PRODUCTION MARKET 2017-2025 ($ MILLION)
FIGURE 16 EUROPE STEM CELL THERAPEUTIC CLONING MARKET 2017-2025 ($ MILLION)
FIGURE 17 EUROPE IVF STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 18 EUROPE STEM CELLS CULTURE MARKET 2017-2025 ($ MILLION)
FIGURE 19 EUROPE STEM CELLS CRYOPRESERVATION MARKET 2017-2025 ($ MILLION)
FIGURE 20 EUROPE STEM CELL EXPANSION AND SUB-CULTURE MARKET 2017-2025 ($ MILLION)
FIGURE 21 EUROPE STEM CELLS MARKET BY APPLICATION 2017 & 2025 ($ MILLION)
FIGURE 22 EUROPE STEM CELLS REGENERATIVE MEDICINE MARKET 2017-2025 ($ MILLION)
FIGURE 23 EUROPE DRUG DISCOVERY AND DEVELOPMENT MARKET 2017-2025 ($ MILLION)
FIGURE 24 GEOGRAPHIC OUTLOOK 2016 & 2025 (%)
FIGURE 25 EUROPE STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 26 EUROPE STEM CELL MARKET REGIONAL OUTLOOK 2016 & 2025 %)
FIGURE 27 UNITED KINGDOM (UK) STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 28 FRANCE STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 29 AGE STRUCTURE OF GERMANY 2015
FIGURE 30 POPULATION AGED ABOVE 65 YEARS 2005 & 2015 (% OF POPULATION)
FIGURE 31 GERMANY STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 32 SPAIN STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 33 ITALY STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 34 ROE STEM CELL MARKET 2017-2025 ($ MILLION)
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
4. MARKET DETERMINANTS
4.1. MARKET DRIVER
4.1.1. UPSURGE IN NEURODEGENERATIVE AILMENTS
4.1.2. INVESTMENTS IN R&D IS GROWING
4.1.3. GOVERNMENT SUBSIDY AND SUSTENANCE
4.1.4. ADVANCEMENTS IN THE APPLICATIONS OF STEM CELL
4.1.5. SIGNIFICANT GROWTH IN MEDICAL TOURISM
4.1.6. SWELLING STEM CELL BANKING
4.2. MARKET RESTRAINTS
4.2.1. STEM CELL TREATMENT INCURS HUGE COST
4.2.2. AVERSION IN REIMBURSEMENT POLICIES
4.3. MARKET OPPORTUNITIES
4.3.1. RISING INVESTMENT IN THE STEM CELL MARKET
4.3.2. REPLACED THE USE OF ANIMAL TISSUES FOR THE EXPERIMENTS
4.3.3. GROWING INCOME OF THE PEOPLE ALL ACROSS THE WORLD
4.3.4. CONTINUE SUPPORT OF CONTRACT RESEARCH INDUSTRY
4.4. MARKET CHALLENGES
4.4.1. STRINGENT GOVERNMENT REGULATIONS
4.4.2. FEWER RESPONSIVENESS IN THE DEVELOPED ECONOMIES
5. MARKET SEGMENTATION
5.1. BY PRODUCTS
5.1.1. ADULT STEM CELL MARKET
5.1.1.1. HEMATOPOIETIC STEM CELL MARKET
5.1.1.2. MESENCHYMAL STEM CELL MARKET
5.1.1.3. NEURAL STEM CELL MARKET
5.1.1.4. DENTAL STEM CELL MARKET
5.1.1.5. UMBILICAL CORD STEM CELL MARKET
5.1.2. HUMAN EMBRYONIC STEM CELL
5.1.3. INDUCED PLURIPOTENT STEM CELL MARKET
5.1.4. RAT NEURAL STEM CELL MARKET
5.2. BY TECHNOLOGY
5.2.1. STEM CELL ACQUISITION MARKET
5.2.1.1. STEM CELL BONE MARROW MARKET
5.2.1.2. STEM CELL APHERESIS MARKET
5.2.1.3. STEM CELL UMBILICAL CORD BLOOD MARKET
5.2.2. STEM CELL PRODUCTION MARKET
5.2.2.1. THERAPEUTIC CLONING FOR STEM CELL MARKET
5.2.2.2. IVF STEM CELL MARKET
5.2.2.3. STEM CELL CULTURE MARKET
5.2.3. STEM CELL CRYOPRESERVATION MARKET
5.2.4. STEM CELLS EXPANSION AND SUB-CULTURE MARKET
5.3. STEM CELLS MARKET BY APPLICATION
5.3.1. STEM CELLS REGENERATIVE MEDICINE MARKET
5.3.2. DRUG DISCOVERY AND DEVELOPMENT MARKET
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. VALUE CHAIN ANALYSIS
6.4. OPPORTUNITY MATRIX
6.5. KEY BUYING CRITERIA
6.5.1. HIGH PRICE
6.5.2. EFFICACY
6.5.3. APPLICATION AND EFFECTIVENESS
6.5.4. ACCURACY
6.6. STRATEGIC RECOMMENDATION & STRATEGIC CONCLUSIONS
6.7. VENDOR LANDSCAPE
7. GEOGRAPHICAL ANALYSIS
7.1. EUROPE STEM CELL MARKET
7.1.1. UK STEM CELL MARKET
7.1.2. FRANCE STEM CELL MARKET
7.1.3. GERMANY STEM CELL MARKET
7.1.4. SPAIN STEM CELL MARKET
7.1.5. ITALY STEM CELL MARKET
7.1.6. ROE STEM CELL MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.1.1. TOP WINNING STRATEGIES
9. COMPANY PROFILE
9.1. CYTORI THERAPEUTICS INC.
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT ANALYSIS
9.1.4. STRATEGIC ANALYSIS
9.2. FIBROCELL SCIENCE
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. CELLARTIS AB (ACQUIRED BY TAKARA HOLDINGS INC.)
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. STRATEGIC INITIATIVES
9.3.4. SCOT ANALYSIS
9.3.5. STRATEGIC ANALYSIS
9.4. BIOTIME INC.
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. SCOT ANALYSIS
9.4.4. STRATEGIC ANALYSIS
9.5. GE HEALTHCARE
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. THERMO FISHER SCIENTIFIC PVT. LTD
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVE
9.6.4. SCOT ANALYSIS
9.6.5. STRATEGIC ANALYSIS
9.7. STEMCELL TECHNOLOGIES
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT ANALYSIS
9.7.5. STRATEGIC ANALYSIS
9.8. CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT ANALYSIS
9.8.5. STRATEGIC ANALYSIS
9.9. VERICEL CORPORATION (AASTROM BIOSCIENCE)
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. BRAINSTORM CELL THERAPEUTICS
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. SCOT ANALYSIS
9.10.4. STRATEGIC ANALYSIS
9.11. CALIFORNIA STEM CELL INC. (HOLDING COMPANY CALADRIUS BIOSCIENCES, INC)
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGICINITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGICANALYSIS
9.12. BECKTON DICKINSON AND COMPANY
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. SCOT
9.12.4. STRATEGIC ANALYSIS
9.13. STRYKER CORPORATION
9.13.1. OVERVIEW
9.13.2. PRODUCTPORTFOLIO
9.13.3. SCOT
9.13.4. STRATEGICANALYSIS
9.14. CORNING INC.
9.14.1. OVERVIEW
9.14.2. PRODUCT PORTFOLIO
9.14.3. SCOT ANALYSIS
9.14.4. STRATEGIC ANALYSIS
9.15. CELGENE CORPORATION
9.15.1. OVERVIEW
9.15.2. PRODUCTPORTFOLIO
9.15.3. STRATEGIC INITIATIVE
9.15.4. SCOT ANALYSIS
9.15.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 EUROPE STEM CELLS MARKET BY PRODUCTS 2017-2025 ($ MILLION)
TABLE 2 ADULT STEM CELL MARKET 2017-2025 ($ MILLION)
TABLE 3 EUROPE STEM CELL MARKET IN HEMATOPOITIC STEM CELL 2017-2025 ($ MILLION)
TABLE 4 EUROPE STEM CELL MARKET IN MESENCHYMAL STEM CELL 2017-2025 ($ MILLION)
TABLE 5 EUROPE STEM CELL MARKET IN NEURAL STEM CELL 2017-2025 ($ MILLION)
TABLE 6 EUROPE STEM CELL MARKET IN DENTAL STEM CELL 2017-2025 ($ MILLION)
TABLE 7 EUROPE STEM CELL MARKET IN UMBILICAL CORD STEM CELL 2017-2025 ($ MILLION)
TABLE 8 EUROPE STEM CELL MARKET IN HUMAN EMBRYONIC STEM CELL 2017-2025 ($ MILLION)
TABLE 9 EUROPE STEM CELLS MARKET IN INDUCED PLURIPOTENT STEM CELL 2017-2025 ($ MILLION)
TABLE 10 EUROPE STEM CELL MARKET IN RAT NEURAL STEM CELL 2017-2025 ($ MILLION)
TABLE 11 EUROPE STEM CELL MARKET BY TECHNOLOGY 2017-2025 ($ MILLION)
TABLE 12 EUROPE STEM CELL ACQUISITION MARKET 2017-2025 ($ MILLION)
TABLE 13 EUROPE STEM CELL BONE MARROW MARKET 2017-2025 ($ MILLION)
TABLE 14 EUROPE STEM CELL APHERESIS MARKET -2025 ($ MILLION)
TABLE 15 EUROPE STEM CELL UMBLICAL CORD BLOOD MARKET 2017-2025 ($ MILLION)
TABLE 16 EUROPE STEM CELL PRODUCTION MARKET 2017-2025 ($ MILLION)
TABLE 17 EUROPE STEM CELL PRODUCTION MARKET -2025 ($ MILLION)
TABLE 18 EUROPE STEM CELL THERAPEUTIC CLONING MARKET -2025 ($ MILLION)
TABLE 19 EUROPE IVF STEM CELL MARKET -2025 ($ MILLION)
TABLE 20 EUROPE STEM CELL CULTURE MARKET -2025 ($ MILLION)
TABLE 21 EUROPE STEM CELL CRYOPRESERVATION MARKET -2025 ($ MILLION)
TABLE 22 EUROPE STEM CELL EXPANSION AND SUB-CULTURE MARKET -2025 ($ MILLION)
TABLE 23 EUROPE STEM CELLS MARKET BY APPLICATION 2017-2025 ($ MILLION)
TABLE 24 EUROPE STEM CELLS REGENERATIVE MEDICINE MARKET -2025 ($ MILLION)
TABLE 25 EUROPE DRUG DISCOVERY AND DEVELOPMENT MARKET -2025 ($ MILLION)
TABLE 26 EUROPE STEM CELL MARKET 2017-2025($ MILLION)
FIGURES LIST
FIGURE 1 EUROPE STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 2 KEY FINDINGS OF STEM CELL MARKET
FIGURE 3 NIH SPENDING ON STEM CELL RESEARCH BY THE YEAR 2013-2016 IN USD $BILLION
FIGURE 4 NIH SPENDING ON STEM CELL, BY YEARS (USD BILLIONS)
FIGURE 5 EUROPE STEM CELLS MARKET BY PRODUCTS 2017-2025 ($ MILLION)
FIGURE 6 EUROPE STEM CELLS MARKET IN ADULT STEM CELL 2017-2025 ($ MILLION)
FIGURE 7 EUROPE STEM CELL MARKET IN HUMAN EMBRYONIC STEM CELL 2017-2025 ($ MILLION)
FIGURE 8 EUROPE STEM CELLS MARKET IN INDUCED PLURIPOTENT STEM CELL 2017-2025 ($ MILLION)
FIGURE 9 EUROPE STEM CELL MARKET IN RAT NEURAL STEM CELL 2017-2025 ($ MILLION)
FIGURE 10 EUROPE STEM CELL MARKET BY TECHNOLOGY 2017-2025 ($ MILLION)
FIGURE 11 EUROPE STEM CELL MARKET BY ACQUISITION 2017-2025 ($ MILLION)
FIGURE 12 EUROPE STEM CELL BONE MARROW MARKET 2017-2025 ($ MILLION)
FIGURE 13 EUROPE STEM CELL APHERESIS MARKET 2017-2025 ($ MILLION)
FIGURE 14 EUROPE STEM CELL UMBILICAL CORD BLOOD MARKET 2017-2025 ($ MILLION)
FIGURE 15 EUROPE STEM CELL PRODUCTION MARKET 2017-2025 ($ MILLION)
FIGURE 16 EUROPE STEM CELL THERAPEUTIC CLONING MARKET 2017-2025 ($ MILLION)
FIGURE 17 EUROPE IVF STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 18 EUROPE STEM CELLS CULTURE MARKET 2017-2025 ($ MILLION)
FIGURE 19 EUROPE STEM CELLS CRYOPRESERVATION MARKET 2017-2025 ($ MILLION)
FIGURE 20 EUROPE STEM CELL EXPANSION AND SUB-CULTURE MARKET 2017-2025 ($ MILLION)
FIGURE 21 EUROPE STEM CELLS MARKET BY APPLICATION 2017 & 2025 ($ MILLION)
FIGURE 22 EUROPE STEM CELLS REGENERATIVE MEDICINE MARKET 2017-2025 ($ MILLION)
FIGURE 23 EUROPE DRUG DISCOVERY AND DEVELOPMENT MARKET 2017-2025 ($ MILLION)
FIGURE 24 GEOGRAPHIC OUTLOOK 2016 & 2025 (%)
FIGURE 25 EUROPE STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 26 EUROPE STEM CELL MARKET REGIONAL OUTLOOK 2016 & 2025 %)
FIGURE 27 UNITED KINGDOM (UK) STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 28 FRANCE STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 29 AGE STRUCTURE OF GERMANY 2015
FIGURE 30 POPULATION AGED ABOVE 65 YEARS 2005 & 2015 (% OF POPULATION)
FIGURE 31 GERMANY STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 32 SPAIN STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 33 ITALY STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 34 ROE STEM CELL MARKET 2017-2025 ($ MILLION)
